Products Gadobutrol (Gadovist, BAY86-4875)
Gadobutrol (Gadovist, BAY86-4875) Pre-clinical Completed 💤 Quiet Magnetic Resonance Imaging
Magnetic Resonance Imaging, Magnetic Resonance Angiography
Jul 1, 2010 → Apr 1, 2013
About Gadobutrol (Gadovist, BAY86-4875) Gadobutrol (Gadovist, BAY86-4875) is a pre-clinical stage product being developed by Bayer for Magnetic Resonance Imaging. The current trial status is completed. This product is registered under clinical trial identifier NCT01095081. Target conditions include Magnetic Resonance Imaging, Magnetic Resonance Angiography.
Clinical Trials (7) NCT ID Phase Status Start Completion Indication NCT01660841 Phase 3 Completed Sep 1, 2012 Aug 1, 2013 Magnetic Resonance Imaging NCT01344447 Phase 3 Completed May 12, 2011 May 28, 2014 Carotid Stenosis NCT01344460 Phase 3 Completed May 1, 2011 Jul 1, 2012 Renal Artery Obstruction NCT01095081 Pre-clinical Completed Jul 1, 2010 Apr 1, 2013 Magnetic Resonance Imaging NCT00905879 Pre-clinical Completed Jun 1, 2009 Jan 1, 2011 Magnetic Resonance Imaging NCT00874640 Pre-clinical Completed Mar 1, 2009 Nov 1, 2011 Epidemiologic Factors NCT00828737 Approved Completed Dec 1, 2008 Jan 1, 2015 Fibrosis
Product Company Stage Hype Score HRS-9231 + Gadobutrol Jiangsu Hengrui Medicine Phase 2 D1000078 + D1000082 + D1000083 + D1000085 AstraZeneca Phase 1 Gadobutrol (Gadavist/Gadovist, BAY86-4875) Bayer Pre-clinical Gadobutrol (Gadovist, BAY86-4875) + Gadopentetate Dimeglumine (Magnevist, BAY86-4882) Bayer Phase 3 Gadoquatrane (BAY1747846) Bayer Phase 3 Gadopentetate dimeglumine (Magnevist, BAY86-4882, SH L 451A) + Gadopentetate dimeglumine (Magnevist, BAY86-4882, SH L 451A) Bayer Phase 2 GBCAs Bayer Pre-clinical Gadobutrol (Gadovist, BAY86-4875) Bayer Phase 3 BAY1747846 Bayer Phase 1 Gadoterate (Dotarem/Clariscan) + Gadobutrol (Gadavist/Gadovist, BAY86-4875) Bayer Approved Gadoquatrane (BAY1747846) + Gadobutrol + Gadoterate meglumine + Gadoteridol Bayer Phase 3 Gadopentetate dimeglumine (Magnevist, BAY86-6661) Bayer Phase 3 Gadoquatrane (BAY1747846) + Gadobutrol + Gadoterate meglumine + Gadoteridol Bayer Phase 3 Gadobutrol (Gadavist, Gadovist, BAY86-4875) Bayer Phase 1 Gadobutrol (Gadovist, BAY86-4875) Bayer Pre-clinical Gadobutrol (Gadavist, BAY86-4875) Bayer Phase 1 BAY1747846 + Matching placebo Bayer Phase 1 Gadoquatrane (BAY1747846) 0.03 mmol Gd/kg + Gadoquatrane (BAY1747846) 0.1 mmol Gd/kg + Matching placebo Bayer Phase 1 Gadobutrol (Gadavist/Gadovist, BAY86-4875) Bayer Pre-clinical Gadoxetate disodium (Eovist/Primovist, BAY86-4873) Bayer Phase 3
Other Products from Bayer